Fetal RhD NIPT: do all Rh negative patients need Rh immune globulin?
Watch Video
Watch Video
In this talk, we will highlight how early, highly accurate prenatal screening optimizes outcomes for patients with 22q11.2 deletion syndrome, and review recently-published data from a large clinical v
Watch Video
Watch Video
Natera™'s Fetal RhD NIPT (noninvasive prenatal testing) is now available. The test is backed by the largest clinical validation study for fetal RhD in the US to date, and demonstrated 100 percent sens
Watch Video
Read More
To manage pregnancies at high risk for 22q11.2 deletion syndrome (DS), prenatal and neonatal evaluation after high risk cfDNA screening is needed. Supplemental assessments and early intervention can i
Watch Video
Read More
Utility of carrier screening to inform management
Watch Video
Martin et al. 2023 Prenat. Diagn
Read More
Read More
Ryan A, Hunkapiller N, Banjevic M, et al. Fetal Diagn Ther 2016
Read More
Ryan A, Baner J, Demko Z, et al. Genet Med 2013
Read More
Curnow KJ, Wilkins-Haug L, Ryan A, et al. Am J Obstet Gynecol 2015
Read More
Norwitz ER, McNeill G, Kalyan A, et al. Journal of Clinical Medicine 2019
Read More
Jelsema R, Demko ZP, Billing, PR. Ultrasound Obstet Gynecol. 2020
Read More
Schmidt JL, Pizzino A, Nicholl J et al. American Journal of Medical Genetics Part A
Read More
Dar P, Norton ME. American Journal of Obstetrics and Gynecology 2022
Read More
Dar P, Norton ME. American Journal of Obstetrics and Gynecology 2022
Read More
Genetic Counselor Awareness Day 2023
Watch Video
Read More
Loading More...